baber/WOPTO huggingface dataset:
Patent AU-4911490-A (AU)
Title: Baseboard, architectural molding or the like for accommodation and protecting electrical equipment and electrical conductors connected thereto
Inventor: GOUSSIN VINCENT
IPC: H02G3/04
Filed: 1990-02-06
Abstract: The invention concerns an extruded section of the type comprising a body (10), a bottom (11) and lateral flanges (12), and closing means suitable for being extended transversely from one of the lateral flanges (12) to the other of this body (10), with, projecting over its bottom (11), at least one rib (19) suitable for enabling any accessory to be attached thereto and, associated with the body (10) at least one detachable partition (23) as accessory. 
<??>According to the invention, there is also associated with the body (10), as closing means to be substituted, if desired, by a cover capable of being established from one of its lateral flanges (12) to the other, at least one set of at least two covers (20', 20'') which are separate and which are each adapted to be respectively established from one of its lateral flanges (12) to the detachable partition (23) and/or from one such detachable partition (23) to another. 
<??>Application to gutters, plinths, trunking or the like, in particular for electrical devices. 
<IMAGE>
Patent AU-5073893-A (AU)
Title: Method and apparatus for folding bottom panels of a carton blank
Inventor: JANSON MAGNUS
IPC: B31B50/56
Filed: 1993-11-16
Abstract: An apparatus and method for folding the bottom panels (30, 32, 34, 36) of a carton blank (20) is disclosed. The apparatus includes a frame (68), a rotatable supporting assembly (65), two rotatable folding fingers (60) mounted on the frame (68) for inwardly folding the second and fourth bottom panels. A tuck folder (56) is mounted on the rotatable mounting assembly for inwardly folding the third bottom panel. A guide (64) is mounted on the frame (68) for contacting and inwardly folding the first bottom panel, and a bending member (72) is mounted on the rotatable supporting assembly (65) for outwardly folding the bottom panel flap. One portion of the bending member (72) is curved to define a concave surface (78) that faces the tuck folder. The bending member can also be provided with convex surfaces (76, 80) on each side of the concave surface. The method involves folding the bottom panel flap (35) outwardly away from the first bottom panel (30) concurrently with the inward folding of the third bottom panel (34). The folding of the bottom panel flap (35) occurs without prior prefolding of the bottom panel flap. <IMAGE>
Patent AU-5301390-A (AU)
Title: Benzimidazoles
Inventor: NARR BERTHOLD
IPC: A61P13/10
Filed: 1990-04-09
Abstract: The invention relates to benzimidazoles of the formula <IMAGE>  in which R1 to R6 are defined as in claim 1, their 1- and 3-isomer mixtures and their acid addition salts, which have useful properties. The novel compounds are in particular angiotensin II antagonists.
Patent AU-5334196-A (AU)
Title: Method for the preparation of esters of anhydroecgonine
Inventor: MOLDT PETER
IPC: C07D451/02
Filed: 1996-03-22
Abstract: PCT No. PCT/EP96/01277 Sec. 371 Date Nov. 4, 1997 Sec. 102(e) Date Nov. 4, 1997 PCT Filed Mar. 22, 1996 PCT Pub. No. WO96/30371 PCT Pub. Date Oct. 3, 1996The present invention discloses compounds of the formula any mixture thereof, or a pharmaceutically acceptable salt thereof; wherein R, R3, and R4 each have the meanings set forth in the specification. The compounds possess valuable pharmaceutical properties as dopamine reuptake inhibitors.
Patent AU-5406090-A (AU)
Title: Acetylated heterologous polypeptides
Inventor: BRUNNER DAVID PAUL
IPC: C12P21/02
Filed: 1990-01-23
Abstract: An animal somatotropin which has at least one lysine residue corresponding to residues 157, 167, 171 or 180 of the native somatotropin sequence replaced by arginine or glutamine.
Patent AU-5452294-A (AU)
Title: The st-b17 serotonin receptor
Inventor: SIBLEY DAVID R
IPC: A61K38/00
Filed: 1993-10-26
Abstract: Genes encoding the St-B17 serotonin receptor protein were cloned and characterized from a rat striatum mRNA and a human genomic library. The St-B17 receptor has nucleotide and amino acid homology with previously described 5-HT genes and can bind ligands that are known to interact with serotonin receptors. In addition, the levels of intracellular cAMP in cells transfected with the receptor gene respond in a dose dependent manner to introduction of serotonin in the media.
Patent AU-5497598-A (AU)
Title: Benzamidine derivatives
Inventor: TAKAYANAGI MASARU
IPC: C07D211/62
Filed: 1998-01-19
Abstract: Benzamidine derivatives of the following formulae or analogs thereof, i. e., pharmaceutically acceptable salts thereof, are provided. These compounds or salts thereof have a blood-coagulation inhibiting effect based on an excellent effect of inhibiting the action of activated blood coagulation factor X, and they are useful as anticoagulants. <CHEM>
Patent AU-5589280-A (AU)
Title: Support for cable tray
Inventor: BULUSCHEK BRUNO
IPC: F16L3/22
Filed: 1980-02-26
Abstract: A supporting structure for an elongated tray, such as a trough or rack, which is used to contain and support a multiplicity of cables running through a building, includes an elongated arm member which extends transversely beneath the tray, one end of the elongated arm member being connectable to a building wall or to a ceiling-strut suspended from a ceiling, and an elongated axial power strut which has one end connected to the elongated arm member near the end connectable to a building wall or ceiling-strut and the other end connected to the floor of the tray, the strut extending so as to enclose an angle of preferably 45 DEG  with the elongated arm member.
Patent AU-5861799-A (AU)
Title: Use of acetylcholinesterase inhibitors for the preparation of pharmaceutical compositions for the treatment of functional and/or organic pain syndromes
Inventor: NICOLODI MARIA
IPC: A61K31/27
Filed: 1999-09-09
Abstract: Methods of use of donepezil having central action for the treatment of function (migraine and primary fibromyalgia) and/or organic (amputation, "phantom limb", tumoral or traumatic denervation or autoimmune mechanism) central pain syndromes are disclosed.
Patent AU-6206599-A (AU)
Title: Electric toaster equipped with electromagnet/switch assembly
Inventor: MAUFFREY GUY
IPC: A47J37/08
Filed: 1999-10-04
Abstract: A toaster is disclosed including a main frame with a toasting compartment including an electrical resistance heater, a carriage mounted for reciprocation within the toasting compartment so that the bread product to be toasted can be loaded when the carriage is in an upper position and the bread product can be toasted when the carriage is in the lower position, an electromagnet for holding the carriage in the lower position, and a safety assembly for interrupting the supply of electricity to the electrical resistance heater at the end of a toasting cycle independent of the position of the carriage with the subassembly and including a lock to lock the carriage in the lower position, an armature for carrying the lock mounted adjacent to the electromagnet, and a resilient contact to establish electrical contact with the electrical resistance heater when the assembly is in the active position.
Patent AU-6383696-A (AU)
Title: Cryopreservation of diverse plant cells
Inventor: KADKADE PRAKASH G
IPC: A01N1/02
Filed: 1996-06-07
Abstract: The present invention relates to methods for cryopreserving plant cells and to methods for recovering viable plant cells from long or short term cryopreservation. Plant cells to be cryopreserved can be grown in culture and pretreated with a solution containing an cryoprotective agent and, optionally, a stabilizer. Stabilizers are preferably membrane stabilizers such as ethylene inhibitors, oxygen radical scavengers and divalent cations. Cells can also be stabilized by subjecting the culture to a heat shock. Pretreated cells are acclimated to a reduced temperature and loaded with a cryoprotective agent such as DMSO, propylene glycol or polyethylene glycol. Loaded cells are incubated with a vitrification solution which, for example, comprises a solution with a high concentration of the cryoprotective agent. Vitrified cells retain less than about 20% water content and can be frozen at cryopreservation temperatures for long periods of time without significantly altering the genotypic or phenotypic character of the cells. Plant cells may also be cryopreserved by lyophilizing cells prior to exposure to a vitrification solution. The combination of lyophilization and vitrification removes about 80% to about 95% of the plant cell's water. Cells can be successfully cryopreserved for long periods of time and viably recovered. The invention also relates to methods for the recovery of viable plant cells from cryopreservation. Cells are thawed to about room temperature and incubated in medium containing a cryoprotective agent and a stabilizer. The cryoprotective agent is removed and the cells successfully incubated and recovered in liquid or semi-solid growth medium. The invention also relates to the cryopreserved cells and to viable plant cells which have been recovered from long or short term cryopreservation.
Patent AU-6404600-A (AU)
Title: High molecular weight primary aliphatic alcohols obtained from beeswax and pharmaceutical use thereof
Inventor: PEREZ PEDRO P
IPC: A61P25/28
Filed: 2000-06-20
Abstract: The present invention relates to a naturally obtained mixture of higher molecular weight primary aliphatic alcohols which contain 24 to 34 carbon atoms. This invention also relates to the process for obtaining the alcohol mixture by extraction and purification with organic solvents from beeswax without saponification ofthe beeswax. The alcohol mixture obtained from beeswax has enhanced purity and contains a mixture of alcohols having 24, 26, 27, 28, 29, 30, 32 and 34 carbon atoms. The alcohol mixture is useful in pharmaceutical compositions, foodstuffs and dietary supplements and is effective for lowering cholesterol in LDL-C levels so that it is effective in treating hypercholesterolemia. Consequently the composition may be used to reduce the risk of coronary heart disease, the atherosclerotic process (platelet hyperaggregability, ischemia and thrombosis) and also acts as an anti-inflammatory and anti-thrombotic agent. The composition also possesses neurotrophic properties and is useful for improving male sexual activity.
Patent AU-6482600-A (AU)
Title: Molding of a polymer
Inventor: BEZEMER JEROEN MATTIJS
IPC: C08K3/00
Filed: 2000-08-04
Abstract: The invention relates to a process for molding a copolymer of a polyalkylene glycol terephtalate and an aromatic ester, comprising the steps of: 
a) preparing a solution of the copolymer in a suitable first solvent; and 
b) forming a gel of the solution.
Patent AU-6536594-A (AU)
Title: Herbicidal heterocyclic-substituted pyridines
Inventor: KLEEMANN AXEL
IPC: C07D401/14
Filed: 1994-03-25
Abstract: PCT No. PCT/EP94/00969 Sec. 371 Date Feb. 2, 1996 Sec. 102(e) Date Feb. 2, 1996 PCT Filed Mar. 25, 1994 PCT Pub. No. WO94/22833 PCT Pub. Date Oct. 13, 1994The present invention relates to 2,6-substituted pyridines of formula I, their preparation and use as herbicides.
Patent AU-6617794-A (AU)
Title: Processorsystem comprising a processor and a memory field for containing a computer interface
Inventor: ANSTOTZ KARIN HELENE MARIA
IPC: G06F3/0482
Filed: 1994-07-05
Abstract: Known processorsystems comprising a processor and memory fields for containing human computer interfaces each having a number of elements each representing a function are little flexible systems. The processorsystem according to the invention is a very flexible system, by receiving a user code and generating an adjustable code which is allocated to an element and which depends upon the user code. This adjustable code can be a transmissioncode representing transmission information or can be a displaycode like an elementcode representing a displayelement being enabled or disabled or an elementparameter representing a number of times a displayelement has been activated. <IMAGE>
Patent AU-6707196-A (AU)
Title: Pharmaceutical composition containing inhibitors of interferon- gamma
Inventor: FERGUSON MARK WILLIAM JAMES
IPC: A61P17/02
Filed: 1996-08-09
Abstract: The present invention provides compositions for promoting the healing of chronic wounds comprising stimulators of IFN- gamma .
Patent AU-6744181-A (AU)
Title: Austenitic wear resistant steel
Inventor: HARTVIG T
IPC: C22C38/38
Filed: 1981-02-17
Abstract: Austenitic steel having 16-25% Mn, 1,1-2,0% C, 0,2-2,0% Si, 0,5-5% Cr, 0,1-0,5% Ti, 0,3-4,0% Mo with or without addition of up to 0,5% of one or more of Ce, Sn and carbide forming elements like V, W, Nb (Cb), max. 5% Ni and max. 5% Cu, the remainder being Fe and impurities to max. 0,1% P and 0,1% S.
Patent AU-6982787-A (AU)
Title: Method for producing iron
Inventor: TURNER RICHARD EDWIN
IPC: C21B13/14
Filed: 1987-03-09
Abstract: A method for producing iron in an elongated reaction vessel provided with underbath nozzles and top blowing means in which carbonaceous fuels, iron ore and/or prereduced ore are fed to the melt and in which the reaction gases escaping from the melt are afterburned with oxygen-containing gases in one or more stages, the waste gas aperture of the reaction vessel being offset from the reaction zone of the cabonaceous fuels and thus disposed outside the eruption and splashing area, and the waste gas temperature in the waste gas conduit connected to the waste gas aperture being held above the soldifying temperature of the droplets carried along in the waste gas stream, and the waste gas then being cooled to less than 1000 DEG  C. in an adjoining chamber.
Patent AU-7056498-A (AU)
Title: Front axle suspension
IPC: B62D7/08
Filed: 1998-04-21
Abstract: A steering assembly for a work vehicle having a supporting frame is disclosed wherein the steering assembly includes a steerable front axle having an axle defined longitudinally by end portions rocking about respective substantially vertical axes. Each end portion supports a rotatable wheel. The front axle further has a box body connected rigidly to the axle to connect it to the frame in freely rotating manner via the interposition of a first spherical joint. A connecting unit connects the front axle stably to the frame to enable the loads on the wheels to be transmitted to the frame. The connecting unit is provided with a shock-absorbing device for elastically disconnecting the front axle from the frame.
Patent AU-7178298-A (AU)
Title: Magnetic resonance blood pool agents
Inventor: WOULFE STEVEN R
IPC: A61K49/06
Filed: 1997-11-12
Abstract: The present invention provides compositions comprising contrast agents capable of binding non-covalently to blood proteins. The compositions of the invention provide increased residence time of contrast agents in the vasculature, thus providing effective blood pool contrast agents. The invention also provides methods for imaging a patient comprising administering a composition of the invention to a patient and obtaining an image.
Patent AU-7291198-A (AU)
Title: Dynamic drive methods and apparatus for a bistable liquid crystal display
Inventor: YANG DENG-KE
IPC: G02F1/137
Filed: 1998-05-06
Abstract: A flat-panel liquid crystal display. The display includes a flat sheet of bistable chiral nematic liquid crystal material activated by a drive circuit that individually controls the display state of multiple picture elements. The driver circuitry activates the liquid crystal domains with various drive schemes which have any number of different phases to attain various addressing sequence times. At the end of each drive scheme, the texture of the liquid crystal material is allowed to provide either focal conic or twisted planar end states across the two-dimensional array of picture elements. Each drive scheme employs at least a preparation phase and a selection phase to predispose the liquid crystal material to one of the end states.
Patent AU-7397687-A (AU)
Title: Method for controlling a fodder mixing plant and fodder mixing plant for carrying out the method
Inventor: LARSEN EBBE BUSCH
IPC: A23N17/00
Filed: 1987-04-28
Abstract: In order to produce pellets (22) in a pellet press following a recipe which is constantly being adjusted in order that the physical properties of the pellets are optimized in relation to the total production costs, a method is used where control is effected on the basis of a current sampling of the composition of the raw materials (28, 29) and of the pellets (37, 39), and on the basis of a current recording of the raw materials (30, 4, 5) and of the conditioning means (34, 38). In order to ensure this control a coordinating computer unit (23) is used with subordinate computer units for raw material control (24, 25), economy control (42), pellet manufacturing (26) and stock control (27), which produce signals to the coordinating computer unit (23) in order that same may be adjusted (45, 48) on a constant basis, whereafter the pellets are manufactured.
Patent AU-7792294-A (AU)
Title: Antibacterial composition containing multimeric alpha-lactalbumin
Inventor: SABHARWAL HEMANT
IPC: C07K1/16
Filed: 1994-08-16
Abstract: The present invention relates to the use of alpha-lactalbumin in the preparation of preparations to be used in therapeutic or prophylactic treatment and/or for diagnostic use for infections, preferably of the respiratory tract, caused by bacteria, in particular S. pneumoniae and/or H. influenzae. The present invention further relates to essentially pure protein complexes comprising alpha-lactalbumin and the use of these protein complexes for therapeutically or prophylactically treating a bacterial infection, especially infections of the respiratory tract caused by S. pneumoniae and/or H. influenzae.
Patent AU-7807301-A (AU)
Title: Non-peptide ccr1 receptor antagonists in combination with cyclosporin a for the treatment of heart transplant rejection
Inventor: HORUK RICHARD
IPC: C07D241/04
Filed: 2001-07-31
Abstract: This invention is directed to pharmaceutical compositions useful in treating heart transplant rejection in mammals comprising a pharmaceutically acceptable excipient, a therapeutically effective amount of a non-peptide CCR1 receptor antagonist and a sub-nephrotoxic amount of cyclosporin A.
Patent AU-7943191-A (AU)
Title: Sonic generator
Inventor: NYBERG CHRISTOPHER A
IPC: B24B31/027
Filed: 1991-06-28
Abstract: A sonic generator comprises a resonant bar (11), a housing (20) and magnetic excitation (13) units connected between the resonant bar (11) and the housing (20). The magnetic excitation units (13) are connected to the bar (11) at highly stressed points using a mounting connection (14) which is a sleeve having an inside diameter slightly greater than the outside diameter of the bar (11). A resilient elastomer (21) such as urethane is mounted between the sleeve (14) and the resonant member (11). The sonic generator may be used for grinding purposes and, in particular, may be used to grind material exceptionally fine with reduced power consumption. The bar (11) is substantially unrestrained so as to allow substantially free vibration. <IMAGE>
Patent AU-8269098-A (AU)
Title: Faecal collector with optimum containment properties
Inventor: PALUMBO GIANFRANCO
IPC: A61F13/15
Filed: 1998-06-26
Abstract: The present invention relates to a faecal management device with an increased level of comfort. The faecal management device comprises a bag having an aperture, and an anatomically-shaped flange, which surrounds the aperture. The flange provides for adhesive attachment to the perianal area of the wearer. In particular, the bag comprises a wall material having an inner surface and an outer surface with the outer surface being provided with a non-woven layer. In another aspect of the present invention, the faecal management device is used in combination with a disposable diaper. <IMAGE>
Patent AU-8295591-A (AU)
Title: Synthesis of carminic acid and principal intermediates
Inventor: TYMAN JOHN HENRY PAUL
IPC: C07F7/02
Filed: 1991-07-15
Abstract: PCT No. PCT/GB91/01170 Sec. 371 Date Mar. 17, 1993 Sec. 102(e) Date Mar. 17, 1993 PCT Filed Jul. 15, 1991 PCT Pub. No. WO92/01664 PCT Pub. Date Feb. 6, 1992.The invention relates to the synthesis of 6-deoxykermesates, 6-deoxykermesic acid, and carminic acid, based on a reaction of a 2-halogenonapthazarin with a bis-trimethylsilyl-diene.
Patent AU-8393091-A (AU)
Title: Controlled permeability film
Inventor: CHRISTIE GREGOR BRUCE YEO
IPC: C08L67/03
Filed: 1991-08-08
Abstract: A controlled permeability film including a film forming polymer and optionally including a dispersing polymer; and an inert porous filler optionally having a surface modifying agent coated thereon, the inert porous filler being present in an amount effective to reduce the ratio of the carbon dioxide permeability to the oxigen permeability of the film, and wherein the filler has a particle size greater than the intrinsic film thickness of the film forming polymer. A composite packaging article and a packaged produce product are also disclosed.
Patent AU-8510091-A (AU)
Title: Enzyme electrodes wherein the enzyme is enclosed within liposomes
Inventor: VADGAMA PANKAJ MADGANLAL
IPC: C12Q1/00
Filed: 1991-09-12
Abstract: Enzyme electrodes with the enzyme enclosed within liposomes, which are preferably supported on or in a membrane and immobilised there, for example in the membrane pores. The liposomes may be made using lipids (especially phospholipids) and conveniently by "reverse phase evaporation". They may incorporate conventional electrode elements, e.g. the Clark electrode pair (Platinum/Silver) and additional membranes or screens, and used particularly in amperometric measurements. They are preferably used near the phase transition temperature of the lipid and give improved selectivity and facility to measure higher concentrations of active components in the analyte. The enzyme is preferably an oxidase (e.g. glucose oxidase) and useful for measurement (directly or indirectly) of low molecular weight species e.g. hydrogen peroxide generated by enzymic action, and effective for study of biological fluids e.g. blood. Also, modified membranes and electrolytic sensors using the liposome-enclosed enzymes.
Patent AU-8606291-A (AU)
Title: 8-azabicyclo(3.2.1)octylalkylthiazolidinones, a process for their preparation and their use as medicaments
Inventor: HRIB NICHOLAS J
IPC: A61K31/46
Filed: 1991-10-24
Abstract: The present invention relates to novel 8-azabicyclo[3.2.1]octylalkylthiazolidinones of formula <CHEM> wherein R<1> and R<2> are independently hydrogen or alkyl; R<3> and R<4> are independently hydrogen or alkyl; X and Y are independently hydrogen, alkyl, alkoxy, halogen or trifluoromethyl; m is 2, 3 or 4, which are useful for treating psychoses.
Patent AU-8692291-A (AU)
Title: Pharmaceutical composition
Inventor: ASAKURA SOTOO
IPC: A61K31/40
Filed: 1991-10-31
Abstract: A pharmaceutical emulsion composition or solution composition in an organic solvent containing a compound represented by the following chemical formula and having immunosuppressive activity is disclosed: <CHEM>   <IMAGE>